35 GATEHOUSE DRIVE, WALTHAM, MA
Reports Second Quarter 2026 Financial Results and Provides Business Update
Investor Presentation
News, Securities Holder Rights or Indentures
Syndax Pharmaceuticals Approves 2026 Equity Incentive Plan
Announces Private Placement of $250.0 Million of Convertible Senior Notes
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Q2
Q1
FY 2024
Q3
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities